Member AUM
$70 trillion

Virbac Group

VIRP:FP FR0000031577
Key Information
HQ:
France
Market Cap:
$4.08bn
Primary Market:
Europe & Russia
Industry:
Pharmaceutical



Company Information

Company Summary

Virbac S.A. is a pharmaceutical company producing animal food and medicine for veterinarians, breeders & owners to deal with animal pathology. It is dedicated exclusively to animal health. Virbac’s wide range of vaccines and medicines are used in the prevention and treatment of the main pathologies for both companion and food-producing animals.
Virbac

Stay up to date

Sign up to our newsletter to get the latest on our award-winning ESG research, insights & more.

The FAIRR Initiative is part of the Jeremy Coller Foundation, which is a registered charity (no. 1163970) and a company limited by guarantee (no. 9696841) in England and Wales. // © 2023 FAIRR Initiative